Abstract Despite coronavirus disease 2019 (COVID-19) primarily being identified as a
respiratory illness, some patients who seemingly recovered from initial infection, developed …

Growing reports since the beginning of the pandemic and till date describe increased rates
of cardiac complications (CC) in the active phase of coronavirus disease 2019 (COVID-19) …

The impact of coronavirus disease, 2019 (COVID-19), has been profound. Though COVID-
19 primarily affects the respiratory system, it has also been associated with a wide range of …

Background A small minority of people with coronavirus disease 2019 (COVID‐19) develop
a severe illness, characterised by inflammation, microvascular damage and coagulopathy …

Abstract Although coronavirus disease 2019 (COVID-19) predominantly disrupts the
respiratory system, there is accumulating experience that the disease, particularly in its more …

Abstract Purpose of Review Coronavirus disease of 2019 (COVID-19) is a cause of
significant morbidity and mortality worldwide. While cardiac injury has been demonstrated in …

Emerging as a new epidemic, long COVID or post-acute sequelae of coronavirus disease
2019 (COVID-19), a condition characterized by the persistence of COVID-19 symptoms …

In this paper, we provide recommendations on the management of cardiovascular disease
(CVD) among patients with confirmed or suspected coronavirus disease (COVID-19) to …

In December 2019, pneumonia of unknown cause broke out, and currently more than 150
countries around the world have been affected. Globally, as of 5: 46 pm CET, 6 November …

First documented in China in early December 2019, the novel severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) spread rapidly and continues to test the strength of …